Development of athermal ε-martensite in atomized Co–Cr–Mo–C implant alloy powders

Co–Cr–Mo atomized powders containing 0.05 wt.% C were sintered at temperatures above 900 °C for 1 h and then rapidly cooled to room temperature. As a result, various amounts of athermal ε-martensite were produced which increased with increasing sintering temperatures (from 30 vol.% at 950 °C to 70 v...

Full description

Saved in:
Bibliographic Details
Published inActa biomaterialia Vol. 2; no. 6; pp. 685 - 691
Main Authors Song, C.B., Park, H.B., Seong, H.G., López, H.F.
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 01.11.2006
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Co–Cr–Mo atomized powders containing 0.05 wt.% C were sintered at temperatures above 900 °C for 1 h and then rapidly cooled to room temperature. As a result, various amounts of athermal ε-martensite were produced which increased with increasing sintering temperatures (from 30 vol.% at 950 °C to 70 vol.% at 1250 °C). Apparently, the development of ε-embryos was strongly promoted by increasing sintering temperatures due to the development of a high density of ε-nucleation site defects. In addition, athermal martensite readily formed in these powders, suggesting that its development was strongly favored by a significant reduction in the carbon supersaturation levels from 0.25 wt.% for most commercial alloys to 0.05 wt.% C. The amounts of ε-martensite were 3–4-fold those found in conventional alloys, suggesting that the powder structure provides increasing nucleation sites for athermal ε-martensite. Apparently free surfaces and grain development at powder contact surfaces combined with recrystallization and grain growth within powder particles lead to favorable dislocation configuration arrays for the development of ε-embryos.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:1742-7061
1878-7568
DOI:10.1016/j.actbio.2006.04.003